Skip to content
Tenfell
Awarded contract
Published 23 Aug 2024

NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections

Western Health and Social Care Trust · Northern Ireland

Key facts

Contract value
£1,532,304
Awarded
15 Aug 2024
Procedure
Award procedure without prior publication of a call for competition
Buyer type
Health

Awarded to

SupplierValue
Novartis Pharmaceuticals UK Ltd£1,532,304

Description

Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.

Categories (CPV)

Similar open tenders

About Western Health and Social Care Trust

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.